NovaBay Pharmaceuticals is leaving eye care behind. The California-based firm announced a strategic pivot to digital finance, rebranding as Stablecoin Development Corporation. Markets reacted immediately, with shares climbing 19% to $1.38 following the news.

CEO Michael Kazley framed the move as a shift toward high-yield digital infrastructure. Effective April 3, the stock ticker switches from NBY to SDEV. Data teams updating financial pipelines must account for this ticker change in ingestion systems. The company isn't just changing letterhead; it has accumulated two billion SKY tokens, controlling over 8% of the total supply. SEC filings from January outlined the new on-chain holding framework, backed by a $134 million private placement involving Tether Investments.

For data professionals tracking corporate asset shifts, the transparency is notable. The firm reports 26.6 million SKY tokens in cumulative staking rewards, verifiable on-chain. While SKY currently trades around $0.073, the company plans to acquire more on the open market. Kazley noted that yield-bearing stablecoins function as productive financial assets, unlocking new primitives for treasury management.

This follows a trend seen throughout 2025 where distressed firms adopted crypto strategies to regain footing. However, with digital asset markets cooling since October, analysts warn of potential consolidation. NovaBay's framework currently approves only SKY tokens, though management signaled interest in broader yield-bearing instruments. As the company transitions from biopharmaceuticals to protocol-level economic activity, investors will be watching how well legacy structures adapt to volatile on-chain networks. The shift highlights how traditional equity data may soon require integration with decentralized ledgers for accurate valuation modeling.

Source: CoinTelegraph